Get started
AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT)AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT)AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT)

AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0A8M chart


Full chart

0A8M upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.79 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
0.20 USD
Net income (FY)
‪−15.84 M‬ USD
Revenue (FY)
‪81.00 M‬ USD
Shares float
‪5.99 M‬
Beta (1Y)
2.14

Employees


Employees (FY)
102
Change (1Y)
−48 −32.00%
Revenue / Employee (1Y)
‪794.14 K‬ USD
Net income / Employee (1Y)
‪−155.33 K‬ USD

About Aytu BioPharma, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Joshua R. Disbrow
Website
aytubio.com
Headquarters
Englewood
Founded
2002
FIGI
BBG0101PY0G6
Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0A8M news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 0A8M.

Frequently Asked Questions


The current price of 0A8M is 2.20 USD — it has increased by 33.33% in the past 24 hours. Watch AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stocks are traded under the ticker 0A8M.
We've gathered analysts' opinions on AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) future price: according to them, 0A8M price has a max estimate of 8.00 USD and a min estimate of 8.00 USD. Watch 0A8M chart and read a more detailed AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stock forecast: see what analysts think of AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) and suggest that you do with its stocks.
0A8M reached its all-time high on Apr 26, 2021 with the price of 142.50 USD, and its all-time low was 1.36 USD and was reached on Dec 23, 2024. View more price dynamics on 0A8M chart.
See other stocks reaching their highest and lowest prices.
0A8M stock is 25.00% volatile and has beta coefficient of 2.14. Track AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stock price on the chart and check out the list of the most volatile stocks — is AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) there?
Today AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) has the market capitalization of ‪11.79 M‬, it has increased by 107.20% over the last week.
Yes, you can track AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) is going to release the next earnings report on Sep 25, 2025. Keep track of upcoming events with our Earnings Calendar.
0A8M earnings for the last quarter are 0.20 USD per share, whereas the estimation was −0.17 USD resulting in a 217.65% surprise. The estimated earnings for the next quarter are 0.31 USD per share. See more details about AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) earnings.
AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) revenue for the last quarter amounts to ‪18.45 M‬ USD, despite the estimated figure of ‪13.74 M‬ USD. In the next quarter, revenue is expected to reach ‪19.61 M‬ USD.
0A8M net income for the last quarter is ‪3.99 M‬ USD, while the quarter before that showed ‪788.00 K‬ USD of net income which accounts for 406.85% change. Track more AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) financial stats to get the full picture.
No, 0A8M doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 29, 2025, the company has 102 employees. See our rating of the largest employees — is AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) EBITDA is ‪7.02 M‬ USD, and current EBITDA margin is 6.65%. See more stats in AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) financial statements.
Like other stocks, 0A8M shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stock shows the neutral signal. See more of AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.